SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001144204-18-037559
Filing Date
2018-07-06
Accepted
2018-07-06 17:11:01
Documents
2
Group Members
MAYNE PHARMA GROUP LTDMAYNE PHARMA INTERNATIONAL PTY LTD

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tv498046_sc13da.htm SC 13D/A 77902
2 EXHIBIT 99.1 tv498046_ex99-1.htm EX-99.1 4460
  Complete submission text file 0001144204-18-037559.txt   84108
Mailing Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606
Business Address 324 SOUTH HYDE PARK AVENUE SUITE 350 TAMPA FL 33606 (813) 864-2559
HedgePath Pharmaceuticals, Inc. (Subject) CIK: 0001042418 (see all company filings)

IRS No.: 541641133 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-51823 | Film No.: 18943002
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address 1538 MAIN NORTH ROAD SALISBURY SOUTH, SA C3 5106
Business Address 1538 MAIN NORTH ROAD SALISBURY SOUTH, SA C3 5106 011-61-8-8209-2666
Mayne Pharma Ventures Pty Ltd (Filed by) CIK: 0001611535 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: SC 13D/A